疼痛管理の世界市場レポート2025年

疼痛管理の市場規模は、今後数年間で安定した成長が見込まれます。2029年の年間平均成長率（CAGR）は4.5%で、920億9,000万米ドルに成長します。このような成長が見込まれる背景には、長期的な疼痛緩和に対するニーズの高まり、高齢化人口の増加、ヘルスケアサービスの拡大、疼痛ケアに関する教育の向上、ヘルスケアシステムの強化を目的とした政府プログラムなどがあります。市場に影響を与えると予想される主な動向には、高度なヘルスケア技術の台頭、疼痛治療法の革新、治療におけるバーチャルリアリティ（VR）の利用、デジタル治療薬（DTx）の採用、非オピオイド鎮痛薬へのシフトなどがあります。

慢性疼痛疾患の有病率の増加は、疼痛管理市場の拡大を牽引すると予測されます。慢性疼痛は、3カ月以上続く持続的な不快感と定義され、多くの場合、怪我や病気の通常の治癒期間を超えて継続します。このような慢性疼痛患者の増加は、肥満率の上昇に大きく関連しており、過剰な体重が関節や筋肉に負担をかけ、変形性関節症や腰痛などの症状を引き起こすからです。疼痛管理では、不快感を和らげ、生活の質を向上させる標的療法を提供することで、慢性疼痛に対処しています。これらの治療は、個人に合わせたケアプランを提供し、日々の仕事を楽にし、全体的な幸福感を高めます。例えば、2023年3月、英国のOffice for Health Improvement and Disparitiesは、16歳以上の個人の17.6%が2022年に関節炎や慢性的な背中や関節の問題などの長期的な筋骨格系の状態にあると報告し、これは2021年の17.0%から増加しています。このような慢性疼痛患者の増加が疼痛管理市場の成長に寄与しています。

疼痛管理市場の主要プレーヤーは、ターゲットを絞ったドラッグデリバリーを改善し、患者のアドヒアランスを高め、副作用を軽減するために、経皮吸収型薬剤のような先進的な薬剤製剤への投資を増やしています。経皮吸収型製剤は、パッチ、ゲル、クリームなどを介して皮膚から投与されます。2025年2月、米国を拠点とする経皮ドラッグデリバリー企業Aveva Drug Delivery Systems Inc.は、中等度から重度の慢性疼痛を治療するために3日間使用できるように設計されたフェンタニルのジェネリック経皮パッチを発表しました。この製品は、強力なオピオイド鎮痛薬であるフェンタニルを皮膚から血流に安定的に送り込み、安定した鎮痛効果を発揮します。また、長時間の装着を可能にする安全な粘着剤や、安全な使用を促す不正開封防止デザインなどの特長も備えています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の疼痛管理：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の疼痛管理市場：成長率分析
• 世界の疼痛管理市場の実績：規模と成長, 2019-2024
• 世界の疼痛管理市場の予測：規模と成長, 2024-2029, 2034F
• 世界の疼痛管理：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の疼痛管理市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• 理学療法
• 介入手順
• 代替療法
• 世界の疼痛管理市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• 抗けいれん薬
• 鎮静剤
• 麻薬
• 片頭痛専門医
• 抗うつ薬
• その他のタイプ
• 世界の疼痛管理市場購入方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 店頭
• 処方箋に基づく
• 世界の疼痛管理市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経障害性疼痛
• がんの痛み
• 顔の痛みと片頭痛
• 筋骨格系の痛み
• 線維筋痛症
• 慢性的な腰痛
• 関節痛
• 頭痛
• 術後の痛み
• 世界の疼痛管理市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 製薬会社
• 医療機器企業
• 調査機関
• 学術機関
• その他のエンドユーザー
• 世界の疼痛管理市場、医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• オピオイド
• 抗けいれん薬
• 抗うつ薬
• コルチコステロイド
• 局所鎮痛剤
• 筋弛緩剤
• カンナビノイド
• 世界の疼痛管理市場理学療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 運動療法
• 手技療法
• 温熱療法と冷却療法
• 電気刺激（TENS）
• 超音波療法
• ハイドロセラピー
• ストレッチとモビリティプログラム
• 姿勢と人間工学のトレーニング
• 世界の疼痛管理市場介入処置の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経ブロック
• 硬膜外ステロイド注射
• 高周波アブレーション
• 脊髄刺激療法
• 脊髄内ドラッグデリバリーシステム
• 関節注射
• 椎間関節注射
• 椎体形成術と後弯形成術
• 世界の疼痛管理市場代替療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鍼
• カイロプラクティックケア
• ヨガと瞑想
• ハーブ療法
• アロマセラピー
• バイオフィードバック療法
• レイキとエネルギーヒーリング
• ホメオパシー

第7章 地域別・国別分析

• 世界の疼痛管理市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の疼痛管理市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 疼痛管理市場：競合情勢
• 疼痛管理市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca PLC
• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• Medtronic plc
• Eli Lilly and Company
• Becton, Dickinson and Company
• Teva Pharmaceutical Industries Ltd
• Boehringer Ingelheim International GmbH
• Boston Scientific Corporation
• Regeneron Pharmaceuticals Inc.
• Baxter International Inc.
• Mallinckrodt Pharmaceuticals plc
• Purdue Pharma L.P.
• Nevro Corp.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 疼痛管理市場2029：新たな機会を提供する国
• 疼痛管理市場2029：新たな機会を提供するセグメント
• 疼痛管理市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pain management is a medical specialty focused on identifying, addressing, and preventing pain to enhance a patient's quality of life. It employs a range of methods and treatments aimed at managing both acute and chronic pain. The main goal of pain management is to relieve discomfort, restore functionality, and promote overall well-being.

Pain management treatments primarily include medications, physical therapy, and alternative methods. Medications are used to ease pain from mild to severe and encompass several types, such as non-steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, sedatives, narcotics, antimigraine agents, antidepressants, and others. These drugs are available through over-the-counter or prescription channels and are applied to treat various conditions like neuropathic pain, cancer-related pain, facial pain and migraines, musculoskeletal disorders, fibromyalgia, chronic back pain, joint pain, headaches, and postoperative discomfort. Key users of these treatments include hospitals and clinics, pharmaceutical and medical device companies, research and academic institutions, and others.

The pain management market research report is one of a series of new reports from The Business Research Company that provides pain management market statistics, including pain management industry global market size, regional shares, competitors with a pain management market share, pain management market segments, market trends and opportunities, and any further data you may need to thrive in the pain management industry. This pain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pain management market size has grown steadily in recent years. It will grow from $73.77 billion in 2024 to $77.30 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. Factors contributing to this historical growth include improved disposable income levels, enhanced healthcare infrastructure, a rising prevalence of diseases linked to modern lifestyles, increased use of minimally invasive and non-opioid pain therapies, and heightened awareness about managing pain effectively.

The pain management market size is expected to see steady growth in the next few years. It will grow to $92.09 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. This anticipated growth is supported by the growing need for long-term pain relief, a larger aging population, expanded healthcare services, improved education about pain care, and government programs aimed at strengthening healthcare systems. Key trends expected to influence the market include the rise of sophisticated healthcare technologies, innovations in pain treatment methods, the use of virtual reality (VR) in therapy, the adoption of digital therapeutics (DTx), and the shift toward non-opioid painkillers.

The growing prevalence of chronic pain conditions is anticipated to drive the expansion of the pain management market. Chronic pain is defined as persistent discomfort lasting more than three months and often continues beyond the normal healing time of an injury or illness. This increase in chronic pain cases is largely linked to rising obesity rates, as excess body weight puts added stress on joints and muscles, resulting in conditions like osteoarthritis and lower back pain. Pain management addresses chronic pain by offering targeted therapies that alleviate discomfort and improve the quality of life. These treatments provide personalized care plans, making daily tasks easier and enhancing overall well-being. For example, in March 2023, the Office for Health Improvement and Disparities in the UK reported that 17.6% of individuals aged 16 and older had a long-term musculoskeletal condition, such as arthritis or chronic back or joint problems, in 2022-an increase from 17.0% in 2021. This rise in chronic pain cases is contributing to the growth of the pain management market.

Key players in the pain management market are increasingly investing in advanced drug formulations like transdermal drugs to improve targeted drug delivery, enhance patient adherence, and reduce adverse effects. Transdermal drugs are administered through the skin via patches, gels, or creams. In February 2025, Aveva Drug Delivery Systems Inc., a U.S.-based transdermal drug delivery company, introduced a generic fentanyl transdermal patch designed for three-day use to treat moderate to severe chronic pain. This product steadily delivers fentanyl, a powerful opioid analgesic, through the skin and into the bloodstream, providing consistent pain relief. The patch also includes features such as a secure adhesive for prolonged wear and a tamper-evident design to encourage safe use.

In October 2024, Stryker Corporation, a U.S.-based medical technology firm, acquired Vertos Medical Inc. in an effort to strengthen its non-surgical treatment offerings and expand its footprint in ambulatory surgery centers. This acquisition includes Vertos Medical's minimally invasive mild procedure, aimed at enhancing chronic pain management. Vertos Medical is a U.S.-based medical device company focused on minimally invasive solutions for chronic pain.

Major players in the pain management market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc , Medtronic plc, Eli Lilly and Company, Becton, Dickinson and Company , Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Regeneron Pharmaceuticals Inc., Baxter International Inc., Mallinckrodt Pharmaceuticals plc, Purdue Pharma L.P., Nevro Corp.

North America was the largest region in the pain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pain management report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pain management market includes revenues earned by entities through medication management, rehabilitation and psychological counseling, and interventional procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pain Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pain management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pain management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pain management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Medication; Physical Therapy; Interventional Procedures; Alternative Therapies
• 2) By Type: Non-Steroidal Anti-Inflammatory Drugs (NSAIDS); Anticonvulsants; Sedatives; Narcotics; Antimigraine Specialists; Antidepressants; Other Types
• 3) By Mode Of Purchase: Over The Counter; Prescription-Based
• 4) By Indication: Neuropathic Pain; Cancer Pain; Facial Pain And Migraine; Musculoskeletal Pain; Fibromyalgia; Chronic Back Pain; Joint Pain; Headache; Post Operative Pain
• 5) By End-User: Hospitals And Clinics; Pharmaceutical Companies; Medical Device Companies; Research Institutions; Academic Institutions; Other End-Users
• Subsegments:
• 1) By Medication: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Opioids; Anticonvulsants; Antidepressants; Corticosteroids; Topical Analgesics; Muscle Relaxants; Cannabinoids
• 2) By Physical Therapy: Exercise Therapy; Manual Therapy; Heat And Cold Therapy; Electrical Stimulation (TENS); Ultrasound Therapy; Hydrotherapy; Stretching And Mobility Programs; Postural And Ergonomic Training
• 3) By Interventional Procedures: Nerve Blocks; Epidural Steroid Injections; Radiofrequency Ablation; Spinal Cord Stimulation; Intrathecal Drug Delivery Systems; Joint Injections; Facet Joint Injections; Vertebroplasty And Kyphoplasty
• 4) By Alternative Therapies: Acupuncture; Chiropractic Care; Yoga And Meditation; Herbal Remedies; Aromatherapy; Biofeedback Therapy; Reiki And Energy Healing; Homeopathy
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co Inc.; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pain Management Market Characteristics

3. Pain Management Market Trends And Strategies

4. Pain Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pain Management Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pain Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pain Management Market Growth Rate Analysis
• 5.4. Global Pain Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pain Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pain Management Total Addressable Market (TAM)

6. Pain Management Market Segmentation

• 6.1. Global Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Physical Therapy
• Interventional Procedures
• Alternative Therapies
• 6.2. Global Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
• Anticonvulsants
• Sedatives
• Narcotics
• Antimigraine Specialists
• Antidepressants
• Other Types
• 6.3. Global Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Over The Counter
• Prescription-Based
• 6.4. Global Pain Management Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuropathic Pain
• Cancer Pain
• Facial Pain And Migraine
• Musculoskeletal Pain
• Fibromyalgia
• Chronic Back Pain
• Joint Pain
• Headache
• Post Operative Pain
• 6.5. Global Pain Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Pharmaceutical Companies
• Medical Device Companies
• Research Institutions
• Academic Institutions
• Other End-Users
• 6.6. Global Pain Management Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Opioids
• Anticonvulsants
• Antidepressants
• Corticosteroids
• Topical Analgesics
• Muscle Relaxants
• Cannabinoids
• 6.7. Global Pain Management Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exercise Therapy
• Manual Therapy
• Heat And Cold Therapy
• Electrical Stimulation (TENS)
• Ultrasound Therapy
• Hydrotherapy
• Stretching And Mobility Programs
• Postural And Ergonomic Training
• 6.8. Global Pain Management Market, Sub-Segmentation Of Interventional Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nerve Blocks
• Epidural Steroid Injections
• Radiofrequency Ablation
• Spinal Cord Stimulation
• Intrathecal Drug Delivery Systems
• Joint Injections
• Facet Joint Injections
• Vertebroplasty And Kyphoplasty
• 6.9. Global Pain Management Market, Sub-Segmentation Of Alternative Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acupuncture
• Chiropractic Care
• Yoga And Meditation
• Herbal Remedies
• Aromatherapy
• Biofeedback Therapy
• Reiki And Energy Healing
• Homeopathy

7. Pain Management Market Regional And Country Analysis

• 7.1. Global Pain Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pain Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pain Management Market

• 8.1. Asia-Pacific Pain Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pain Management Market

• 9.1. China Pain Management Market Overview
• 9.2. China Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pain Management Market

• 10.1. India Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pain Management Market

• 11.1. Japan Pain Management Market Overview
• 11.2. Japan Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pain Management Market

• 12.1. Australia Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pain Management Market

• 13.1. Indonesia Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pain Management Market

• 14.1. South Korea Pain Management Market Overview
• 14.2. South Korea Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pain Management Market

• 15.1. Western Europe Pain Management Market Overview
• 15.2. Western Europe Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pain Management Market

• 16.1. UK Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pain Management Market

• 17.1. Germany Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pain Management Market

• 18.1. France Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pain Management Market

• 19.1. Italy Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pain Management Market

• 20.1. Spain Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pain Management Market

• 21.1. Eastern Europe Pain Management Market Overview
• 21.2. Eastern Europe Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pain Management Market

• 22.1. Russia Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pain Management Market

• 23.1. North America Pain Management Market Overview
• 23.2. North America Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pain Management Market

• 24.1. USA Pain Management Market Overview
• 24.2. USA Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pain Management Market

• 25.1. Canada Pain Management Market Overview
• 25.2. Canada Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pain Management Market

• 26.1. South America Pain Management Market Overview
• 26.2. South America Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pain Management Market

• 27.1. Brazil Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pain Management Market

• 28.1. Middle East Pain Management Market Overview
• 28.2. Middle East Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pain Management Market

• 29.1. Africa Pain Management Market Overview
• 29.2. Africa Pain Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pain Management Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pain Management Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pain Management Market Competitive Landscape And Company Profiles

• 30.1. Pain Management Market Competitive Landscape
• 30.2. Pain Management Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Pain Management Market Other Major And Innovative Companies

• 31.1. AstraZeneca PLC
• 31.2. Abbott Laboratories
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline plc
• 31.5. Medtronic plc
• 31.6. Eli Lilly and Company
• 31.7. Becton, Dickinson and Company
• 31.8. Teva Pharmaceutical Industries Ltd
• 31.9. Boehringer Ingelheim International GmbH
• 31.10. Boston Scientific Corporation
• 31.11. Regeneron Pharmaceuticals Inc.
• 31.12. Baxter International Inc.
• 31.13. Mallinckrodt Pharmaceuticals plc
• 31.14. Purdue Pharma L.P.
• 31.15. Nevro Corp.

32. Global Pain Management Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pain Management Market

34. Recent Developments In The Pain Management Market

35. Pain Management Market High Potential Countries, Segments and Strategies

• 35.1 Pain Management Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pain Management Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pain Management Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer